# US 2011/0256070 A1 · Pharmaceutical compositions and methods for administering the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2011/0256070 A1
- Document ID: US20110256070A1
- Status: Published application
- Kind: A1
- Application number: 13/088,653
- Filed: 2011-04-18
- Published: 2011-10-20
- Earliest claimed: 2010-04-19
- Assignees: Gelmed, LLC
- Inventors: James H. Martin; Christopher J. Sciarra; John J. Sciarra
- Web page: https://patentgrep.com/patent/US20110256070A1

## CPC

- A61K 9/0019: {Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00)}
- A61K 9/0043: {Nose}
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 9/124: {characterised by the propellant}
- A61K 31/4174: Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A61K 31/485: Morphinan derivatives, e.g. morphine, codeine
- A61K 31/5513: 1,4-Benzodiazepines, e.g. diazepam {or clozapine}
- A61K 31/5517: condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/14: Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A61K 47/44: Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin (synthetic glycerides, e.g. medium-chain triglycerides, A61K47/14)
- A61P 5/00: Drugs for disorders of the endocrine system
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 25/20: Hypnotics; Sedatives
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/04: Antibacterial agents
- A61P 31/10: Antimycotics
- A61K 9/0031: {Rectum, anus}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The present invention provides pharmaceutical compositions and methods for dispensing the same using an aerosol whereby the composition takes the form of foam. Additionally, the present invention provides a barrier system including a concentrate separated from a non-chlorine aerosol propellant wherein the concentrate includes a non-aqueous solvent, an emulsifying agent, a thickening agent, at least one medicament and optionally an aqueous solvent.

## Claims

### Claim 1

A composition comprising a non-aqueous solvent, a non-chlorine aerosol propellant, an emulsifying agent, a thickening agent, at least one medicament and optionally an aqueous solvent.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the aqueous solvent is water.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the non-chlorine aerosol propellant is P-134a, P227ea, P-236fa, P-245fa, P-152a, an atmospheric gas, or a combination of two or more thereof.

### Claim 4 (depends on 1)

The composition of claim 1 wherein the atmospheric gas is air, nitrogen, nitrous oxide, carbon dioxide or a combination of two or more thereof.

### Claim 5 (depends on 1)

The composition of claim 1, wherein the non-aqueous solvent is an alcohol, a glycerol, a glycol or a combination of two or more thereof.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the emulsifying agent is an emulsifying wax, a stearic acid, cetyl alcohol or a combination of two or more thereof.

### Claim 7 (depends on 1)

The composition of claim 1, wherein the emulsifying agent is a combination of an emulsifying wax and a stearic acid.

### Claim 8 (depends on 1)

The composition of claim 1, wherein the thickening agent is a fatty acid, a starch, a vegetable gum, a protein, a sugar, or a combination of two or more thereof.

### Claim 9 (depends on 1)

The composition of claim 1, wherein the sugar is a cyclic oligosaccharide.

### Claim 10 (depends on 1)

The composition of claim 1, wherein at least one medicament is a narcotic blocker, an antibacterial agent, virucidal agent, a fungicidal agent, a beta-blocker, a cardiotropic, a vaso-active agent, a hormone, a decongestant, a vaccine, an analgesic or a sedative.

### Claim 11 (depends on 1)

The composition of claim 1, wherein at least one medicament is midazolam or diazepam.

### Claim 12 (depends on 1)

The composition of claim 1, wherein at least one medicament is naloxone or flumazenil.

### Claim 13 (depends on 1)

The composition of claim 1, wherein at least one medicament is oxymetazoline.

### Claim 14 (depends on 1)

The composition of claim 1, further comprising one or more additives.

### Claim 15 (depends on 1)

A pressure container comprising the composition of claim 1 therein under a pressure greater than atmospheric pressure.

### Claim 16

A barrier system comprising a concentrate separated from a non-chlorine aerosol propellant wherein the concentrate comprises a non-aqueous solvent, an emulsifying agent, a thickening agent, at least one medicament and optionally an aqueous solvent.

### Claim 17 (depends on 16)

The barrier system of claim 16, wherein the non-chlorine aerosol propellant has a higher pressure than the concentrate.

### Claim 18 (depends on 1)

A method for administering the composition of claim 1 to a patient in need thereof comprising discharging a dose of the composition from an aerosol dispenser charged with the composition wherein the aerosol dispenser has either a metering valve or a continuous valve.

### Claim 19 (depends on 18)

The method of claim 18, wherein the composition is discharged into a nostril of the patient and wherein a nasal trumpet is inserted into the nostril prior to discharge of the composition.

### Claim 20 (depends on 18)

The method of claim 18, wherein the composition forms foam upon discharge of the aerosol dispenser.
